David Fellows、Chris Hollowood David Lubner、Professor Robert MacLaren、James McArthur、David Mott
Choroideremia (CHM) | CHM is a rare, degenerative, X-linked genetic retinal disorder primarily affecting males. |
One-time retinal gene therapy | For patients with rare hereditary retinal diseases. |
NSR-REP1 | choroideremia (CHM). |
NSR-RPGR | X-linked retinitis pigmentosa (XLRP) |
NSR-BEST1 | Yolk-like macular dystrophy |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
A轮 | 2014-01 | 未披露 | 未披露 |
创业 | 2014-02 | 未披露 | GBP12M |
B轮 | 2015-11 | New Enterprise Associates | $35M |